BSEIndia
      Close  
NOTICES
Notice No.   20250201-12   Notice Date   01 Feb 2025
Category   Company related   Segment   Equity
Subject   Suspension of trading in equity shares of Parenteral Drugs India Ltd(Scrip Code: 524689)
 
Content

To All Members,

Parenteral Drugs (India) Limited vide its announcement dated January 23, 2024, has informed the Exchange that Hon’ble NCLT, Mumbai Bench, has ordered that the shares of the Company shall automatically stand delisted from all the Stock Exchanges without any cost or liability and the stock exchange shall immediately do the needful to do the delisting.

Further, it may be noted that trading in the shares of the Company is under suspension on account of non-compliance with Regulation 31 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, therefore trading in the shares of the company shall remain suspended till further notice.

 

Scrip Code

Name of the Company

524689

Parenteral Drugs (India) Limited

 

For further clarification on the above, please email on bse.soplodr@bseindia.com

 

   

Manu Thomas  
Addl. General Manager-Listing Compliance 

 

Shyam Bhagirath   
Manager-Listing Compliance

Site optimized for IE8 & above, resolution 1024 X 768 & above. | Disclaimer  |  SitemapCopyright@ 2015. All Rights Reserved. BSE Ltd.    (22)